Sigma Of Australia May Get Lower Buyout Offer From Africa's Aspen
This article was originally published in PharmAsia News
Executive Summary
The suitor for Australia's Sigma Pharmaceuticals plans to trim its previous offer for the company to something below $589 million, an informed source said